Results
T elomere maintenance is essential for the survival of rapidly dividing tumor cells. To achieve this, tumors either re-express telomerase or undergo ALT. The latter is a telomerase-independent mechanism that relies on homology-directed telomere maintenance. ALT occurs in 5-15% of human tumors and is generally associated with poor prognosis [1] [2] [3] . Perhaps the most consistent indicator of ALT is a functional defect in the chromatin remodeler ATRX 4, 5 . Supporting a role for ATRX in ALT, its re-expression was recently shown to suppress ALT hallmarks such as homologous recombination-dependent telomere sister chromatid exchange (T-SCE) through mechanisms that remain to be fully explored [6] [7] [8] . Further supporting a role for chromatin in ALT, loss of the histone chaperone ASF1 resulted in a rapid induction of the ALT phenotype in telomerase-positive cells 9 . Understanding the mechanistic link between chromatin structure and ALT telomere maintenance pathways may, therefore, provide essential insight into the molecular pathways that regulate the growth of these malignant tumor types.
Chromatin perturbations in ALT cells are thought to act primarily by increasing RS susceptibility, which in turn promotes DSB formation to trigger homologous recombination-dependent telomere lengthening 2 . How these processes are coordinated is a matter of intense investigation. Of note, ATRX is recruited to chromatin on RS and its depletion aggravates RS-induced replication fork collapse and DSB formation 10 . Moreover, re-expression of ATRX in ALT cells reduces RS-associated DNA damage, implicating ATRX in the resolution of stalled replication forks 6 . With respect to chromatin, ATRX has been linked to the incorporation of two histone variants, H3.3 and macroH2A1 (refs. [11] [12] [13] ). We recently identified macroH2A1.2, one of two structurally distinct alternative macroH2A1 splice isoforms, as a mediator of homologous recombination and the replication stress (RS) response. Specifically, macroH2A1.2 promotes the recruitment of the tumor suppressor BRCA1 (refs. [14] [15] [16] ), which has been implicated in repair pathway choice at DSBs and stalled replication forks, where it facilitates homologous recombination as well as break-induced replication (BIR) [17] [18] [19] . BIR involves long-tract, conservative DNA synthesis on DNA break formation and subsequent strand invasion, a process recently found to orchestrate homology-directed telomere maintenance in ALT tumors 20 . Together, these findings raise the intriguing possibility that ATRX loss may affect ALT by modulating the mac-roH2A1.2 chromatin landscape at telomeres.
Here, we show that macroH2A1.2 is enriched at telomeres, particularly in ALT cells. Consistent with its role as a homologous recombination mediator, macroH2A1.2 loss results in defective homo logous recombination-associated telomere maintenance. Perhaps more importantly, we identify an ATRX-dependent pathway that maintains macroH2A1.2 levels during acute RS, the absence of which accounts for RS-associated DSB formation in ATRXdeficient cells. MacroH2A1.2 thus presents a tightly regulated modulator of both telomere-associated DNA damage formation and its subsequent homology-directed repair, with direct implications for malignant growth. ends, we performed macroH2A1.2 chromatin immunoprecipitation (ChIP) followed by quantitative PCR (qPCR) using primer sequences against unique subtelomeric genomic loci 21 . Compared with non-fragile control loci, macroH2A1.2 was enriched at subtelomeric chromatin in a total of six cell lines tested. MacroH2A1.2 enrichment was most pronounced in telomerase-negative ALT cell lines, which are particularly susceptible to telomeric RS ( Fig. 1a ) 2 . Using ChIP followed by dot blot to detect TTAGGG telomere repeat DNA, we confirmed abundant macroH2A1.2 occupancy at telomeres in ALT-positive U2OS cells. The telomere-associated shelterin component TRF2 served as a positive control ( Fig. 1b) . No enrichment was observed on ChIP with the centromeric CENP-A protein ( Supplementary Fig. 1a ). Consistent with our previous work 16 , we also observed enrichment of macroH2A1.2 relative to input DNA at non-telomeric Alu repeats, which was, however, approximately tenfold less pronounced than at telomeres ( Supplementary Fig. 1b ). Together, these findings demonstrate that telomeres and subtelomeric regions are marked by the macroH2A1.2 histone variant.
MacroH2A1.2 facilitates homologous recombination-dependent telomere maintenance at DSBs. We next sought to investigate if macroH2A1.2 accumulation at telomeres plays a role in telomere maintenance. Consistent with this notion, RNA interference (RNAi)-mediated depletion of macroH2A1.2 resulted in a reduction in telomere signal intensity in two distinct ALT cell lines as measured by quantitative fluorescent in situ hybridization (Q-FISH) with a telomere-specific DNA probe ( Fig. 1c and Supplementary  Fig. 1c-f ). Short interfering RNAs (siRNA) were directed against two distinct target sequences within the macroH2A1.2-specific exon 6a (si-1.2-1 or si-1.2-2). The efficiency and splice variant specificity of RNAi-mediated macroH2A1.2 depletion was confirmed by western blot ( Supplementary Fig. 1c ). MacroH2A1.2 depletion in the same two ALT cell lines further resulted in a robust decrease in the formation of extrachromosomal telomere (CCCTAA) n DNA circles (C-circles), which are highly specific to ALT cells, provide a responsive marker of ALT activity 22 and have further been linked to elevated telomeric RS 23 ( Fig. 1d and Supplementary Fig. 1g ). To allow for efficient C-circle formation, cells were analyzed 6-12 days after stable, short hairpin RNA (shRNA)-mediated knockdown; shRNA target sequences were identical to those of siRNAs (Supplementary Table 1 ). These data demonstrate that macroH2A1.2 contributes to telomere maintenance and the ALT phenotype.
Consistent with macroH2A1.2 being a mediator of homologous recombination at DSBs 14 , its depletion resulted in an approximately twofold reduction in T-SCE in two distinct ALT cell lines ( Fig. 2a,b and Supplementary Fig. 2a ). T-SCE measures homology-directed telomeric gene conversion events via strand-specific labeling of telomere chromatids to allow for the detection of telomere-specific cross-overs by chromosome orientation fluorescence in situ hybridization (CO-FISH) 24 . To further corroborate a defect in telomeric homologous recombination, we assessed the impact of mac-roH2A1.2 loss on BIR at telomeres. BIR results in de novo DNA synthesis at sites of DSBs following homology-directed invasion of a broken DNA strand in a manner that is distinct from S phase replication 20, 25 . BIR was recently identified as a means for DSBs to enact nascent long-tract telomeric DNA synthesis using intact telomeres as a template 20 . BIR can be measured via the immunofluorescencebased detection of bromodeoxyuridine (BrdU) incorporation.
Using an mCherry-TRF1-FokI fusion protein, which tethers the FokI endonuclease to telomeric repeats via the telomeric protein TRF1 and thus allows for telomere-specific DSB induction 20,26 , we measured BrdU intensity at mCherry-TRF1-FokI foci by immunofluorescence. Depletion of macroH2A1.2 with two distinct shRNAs resulted in a robust decrease in BrdU signal ( Fig. 2d,e ), indicating that macroH2A1.2 promotes BIR at broken telomeres. TRF1-FokI-induced DSB formation was confirmed by the accumulation of S139-phosphorylated histone H2AX (γ-H2AX) at TRF1-FokI foci and was not significantly altered by maroH2A1.2 depletion ( Fig. 2f and Supplementary Fig. 2c ). Of note, ALT telomere maintenance has been linked to RS-induced recruitment of BRCA1 27 , which has in turn been implicated in promoting BIR at stalled replication forks 19 . In line with the fact that macroH2A1.2 promotes BRCA1 recruitment at non-telomeric DSBs 14 , shRNA-mediated macroH2A1.2 depletion caused a marked decrease in BRCA1 at TRF1-FokI-induced DNA breaks ( Fig. 2g,h) . Similar results were observed with an independent siRNA ( Fig. 2i and Supplementary  Fig. 2b,d,e ). Conversely, overexpression of macroH2A1.2 resulted in increased BRCA1 accumulation in the same assay ( Fig. 2j and Supplementary Fig. 2g ). Little γ-H2AX or BRCA1 accumulation was observed with a catalytically dead FokI enzyme (FokI-D450A), demonstrating DSB requirement for efficient DDR activation ( Supplementary Fig. 2f ). Of note, BRCA1 recruitment to telomeric DSBs remained largely unaltered on depletion of the alternative macroH2A1.1 splice isoform ( Supplementary Fig. 2h ). Moreover, depletion of macroH2A1.1 did not impair homologous recombination in a reporter assay ( Supplementary Fig 2i) . These observations emphasize the existence of unique, splice variant-specific functions of macroH2A1 isoforms, and a detailed dissection of the underlying molecular basis will be an important aspect of future investigations. Together, these findings demonstrate that macroH2A1.2 promotes homologous recombination-mediated telomere maintenance, which is correlated with BRCA1 recruitment to telomeric DSBs.
RS promotes acute macroH2A1.2 loss at telomeres of ATRXdeficient cells. Given the protective role for macroH2A1.2 during RS 16 , abundant, homologous recombination-permissive macroH2A1.2 levels at ALT telomeres are seemingly at odds with their increased susceptibility to RS. We, thus, asked whether RS may alter macroH2A1.2 occupancy at ALT telomeres to promote a more RS-prone chromatin environment. Consistent with this notion, exposure of U2OS cells to low levels of the ribonucleotide reductase inhibitor and replication poison hydroxyurea caused a >tenfold loss of subtelomere-associated macroH2A1.2 relative to its nucleosomal binding partner H2B, by ChIP analysis (Fig. 3a) . H2B levels were not substantially affected by RS or ATRX expression ( Supplementary  Fig. 3a ). RS-induced macroH2A1.2 loss at telomeres was confirmed by telomere-specific dot blot (Fig. 3b) . Similar results were observed in two additional ALT cell lines ( Supplementary Fig. 3c,d) and with a distinct source of RS, the DNA polymerase inhibitor aphidicolin (Aph) ( Supplementary Fig. 3b ). No major mac-roH2A1.2 loss was detected at a non-fragile control locus, pointing to an RS-specific change in chromatin ( Fig. 3a and Supplementary  Fig. 3b,c) . Moreover, telomerase-positive tumor cell lines showed little to no RS-induced telomeric macroH2A1.2 loss, suggesting that this phenomenon is specific to ALT cells ( Supplementary Fig. 3c ).
Given that most ALT cell lines, including those tested here, lack expression of the nucleosome remodeler and macroH2A1.2 interactor ATRX 4,5,12,28 , we asked if the absence of ATRX is functionally linked to RS-induced macroH2A1.2 loss at telomeres. To do so, we took advantage of a doxycycline (Dox)-inducible system for ATRX re-expression in U2OS cells, which was shown to repress several hallmarks of ALT through yet to be defined mechanisms 6 . Notably, restoration of ATRX almost completely rescued the hydroxyureainduced macroH2A1.2 loss, as determined by both ChIP at distinct subtelomeric loci and telomere-specific dot blot (Fig. 3a,b) . Conversely, ATRX depletion in ALT-negative K562 cells resulted in RS-induced loss of subtelomeric and telomeric macroH2A1.2, whereas canonical H2A and H2B histones remained largely unaltered ( Fig. 3c and Supplementary Fig. 3e,f) . Affinity purification of recombinant histone dimers containing H2B and either H2A or the histone-like region of macroH2A1 (mH2A1 1-122 ) revealed that ATRX preferentially interacts with the histone-domain of macroH2A1, supporting a role for ATRX in macroH2A1 variantspecific nucleosome remodeling (Fig. 3d ). ATRX deficiency does not, however, generally interfere with macroH2A1.2 accumulation at telomeres, as macroH2A1.2 is abundant at these genomic loci in the absence of RS both in ALT-positive cell lines and ATRX-depleted K562 cells (Fig. 3a-c and Supplementary Fig. 3c-f ). Together, these Supplementary Fig. 3e for corresponding telomere dot blot. d, Affinity purification of recombinant histone dimers containing H2B and either H2A or the histone-like region of macroH2A1 (mH2A1 observations point to a unique, RS-specific role for ATRX in mac-roH2A1.2 maintenance at telomeres that is distinct from its impact on chromatin in the absence of damage.
DNA damage signaling and ATRX coordinate RS-associated macroH2A1.2 remodeling. Given the abundance of macroH2A1.2 at ALT telomeres, we reasoned that mechanisms must exist to counteract RS-induced macroH2A1.2 loss. In ATRX-proficient cells, macroH2A1.2 accumulation at sites of RS is controlled by DDR signaling 16 . We, thus, sought to determine whether the DDR similarly affects macroH2A1.2 levels at ALT telomeres. Consistent with this notion, inhibition of ATM-or ATR-signaling significantly exacerbated macroH2A1.2 loss during hydroxyurea treatment in ALT cells, indicating that DDR signaling counteracts RS-induced macroH2A1.2 depletion in ATRX-deficient cells. Comparatively minor effects were observed at a non-fragile, non-telomeric control locus, consistent with fragile site-specific macroH2A1.2 reorganization described previously ( Fig. 3e and Supplementary Fig. 3g ) 16 . Moreover, in agreement with dynamic macroH2A1.2 depletion and re-accumulation at sites of DSBs 14 , we observed a robust recovery of telomeric macroH2A1.2 levels 6 hours after hydroxyurea removal (Fig. 3f ). In light of these findings, we propose that macroH2A1.2 deposition at sites of RS involves both ATRX-dependent chromatin remodeling and DDR activation, resulting in transient, RS-specific macroH2A1.2 loss in ATRX-deficient cells.
ATRX prevents macroH2A1.2 loss and concomitant excessive DNA damage. We next sought to determine the impact of RS-associated macroH2A1.2 loss on telomeric DNA break formation. We have previously shown that macroH2A1.2 depletion results in a significant increase in fragile site-associated DNA damage in ATRX-proficient K562 cells 16 . The latter is also the case for subtelomeric loci, which show a marked increase in γ-H2AX by ChIP in macroH2A1.2-deficient cells ( Fig. 4a and Supplementary  Fig. 4a ). MacroH2A1.2 ChIP confirmed CRISPR-Cas9-mediated macroH2A1.2 gene inactivation ( Supplementary Fig. 4a ) 16 . We next asked if RS-induced macroH2A1.2 loss in ALT cells is similarly related to DSB formation. To do so, we assessed γ-H2AX induction in U2OS cells on RS in the absence or presence of ATRX re-expression, to allow for or prevent RS-associated macroH2A1.2 loss, respectively. ATRX induction was able to suppress DNA damage at ALT telomeres in response to RS, as determined by γ-H2AX ChIP qPCR at subtelomeric loci and by immunofluorecence for telomere dysfunction-induced foci (TIF) (Fig. 4b,c ). TIFs are defined as DNA damage-bearing telomeres, which are detected by combining γ-H2AX immunofluorescence with telomere-FISH.
To determine whether the protective effect of ATRX is dependent on macroH2A1.2, we re-expressed ATRX in the presence or absence of macroH2A1.2 knockdown followed by a quantification of TIF formation. In contrast to macroH2A1.2-proficient cells, ATRX re-expression did not significantly reduce TIFs in In ALT-positive cells, ATRX deficiency leads to macroH2A1.2 loss and DSBs in response to RS, which triggers DDR-dependent macroH2A1.2 re-deposition to facilitate homologous recombination. In the absence of RS, lack of ATRX has little effect on telomeric macroH2A1.2 levels, pointing to DNA damage-induced modulation of ATRX function, which may involve ATRX phosphorylation in S phase (see Discussion) 35 . macroH2A1.2-depleted cells exposed to RS, supporting the notion that ATRX counteracts RS-induced DNA damage by preventing macroH2A1.2 loss at telomeres (Fig. 4c ). ATRX deficiency thus allows for increased RS at ALT telomeres via acute chromatin reorganization involving the transient depletion of macroH2A1.2. Underlining the potential relevance of these findings for ALT tumor growth, stable depletion of macroH2A1.2 caused a progressive, proliferative defect in two independent ALT cell lines ( Supplementary Fig. 4b-d ), whereas no growth defect was observed in two telomerase-positive and ALT-negative tumor cell lines ( Supplementary Fig. 4e,f ).
Discussion
Here, we identify macroH2A1.2 as a telomere-enriched chromatin component that links ATRX loss to homologous recombinationdependent telomere maintenance. Our findings are consistent with the following model. By promoting acute loss of macroH2A1.2 during RS, the absence of ATRX causes increased DSB formation to initiate ALT. A dynamic, DDR-dependent re-deposition of mac-roH2A1.2 at DSBs allows for macroH2A1.2 restoration at telomeres to facilitate homology-directed repair and, thus, promote the execution of ALT (Fig. 4d ). Together, these findings provide a mechanistic rationale for ATRX loss in tumors that rely on ALT and identify macroH2A1.2 as a potential therapeutic target for the manipulation of ALT tumor growth.
Changes in telomeric chromatin have previously been implicated in ALT-associated telomere maintenance. The nucleosome remodeling and histone deacetylation complex was shown to promote remodeling of telomeric chromatin to create an environment that facilitates T-SCE 29 . More recently, depletion of ASF1 histone chaperones was found to induce ALT in telomerase-positive tumor cells 9 . However, a mechanistic understanding of the role of chromatin in ALT, particularly with regard to ATRX, one of the most commonly mutated chromatin modulators in ALT cells, is missing 4,5 . Our findings now uncover a central role for an ATRXassociated histone variant, macroH2A1.2, during RS and homologous recombination at telomeres. ATRX, together with the DAXX chaperone, has further been implicated in histone H3.3 deposition, which, like ATRX and DAXX, carries potential ALT driver mutations 1, 11, 13 . It will thus be interesting to determine whether changes in macroH2A1.2 and H3.3 deposition can functionally cooperate to modulate RS susceptibility and repair outcome at telomeres of ATRX-deficient cells.
Of note, a previous genome-wide study uncovered an inverse correlation between ATRX and macroH2A1.2 deposition on chromatin 12 . Consistent with this, we observed a modest reduction of macroH2A1.2 at subtelomeric DNA on ATRX re-expression in the absence of RS (see Fig. 3a ), suggesting that ATRX-dependent remodeling of macroH2A1.2 may be differentially regulated in the presence or absence of DNA damage signaling. In support of this notion, ATRX depletion in human cancer cell lines was found to promote DSB formation and replication fork stalling specifically in the presence of RS or DNA damaging agents ( Fig. 4d) 10, 30 . On the other hand, ATRX inactivation in mouse models and primary mouse cells resulted in replication defects, increased DNA damage and telomere dysfunction even in the absence of exogenous DNA damage, suggesting that endogenous RS may be sufficient to trigger replication defects in these models 13, [31] [32] [33] . Pointing to cell cycle-associated changes in ATRX function, ATRX and DAXX accumulate on chromatin at the end of S phase, specifically at late replicating and RS-sensitive heterochromatic regions 34 . Moreover, ATRX was shown to be modulated by phosphorylation at the onset of mitosis, a timepoint that has been associated with fragile site-associated metaphase chromosome breaks and gaps 35, 36 . It will be important for future work to determine whether and how RS affects ATRX function with regard to its chromatin remodeling activities. Similarly, it will be of interest to determine a possible link between ATRX and the FACT chaperone, which we found to promote DDR-dependent macroH2A1.2 reorganization at fragile genomic regions 16 .
ATRX interacts not only with macroH2A1.2, but also with its alternative splice isoform macroH2A1.1. The two macroH2A1 variants differ in 33 amino acids within the macro-domain, which allows macroH2A1.1, but not macroH2A1.2, to bind poly-ADP ribose 37 . Interaction with ATRX was shown to prevent macroH2A1.1 from binding to poly-ADP ribosylated tankyrase, thus enabling tankyrase to localize to telomeres to resolve sister chromatid cohesion 28 . ATRX loss has, thereby, been linked to persistent telomere cohesion and increased T-SCE. Of note, macroH2A1.1 depletion does not impair homologous recombination or BRCA1 accumulation at telomeric DSBs ( Supplementary  Fig. 2h,i) . We, thus, conclude that, while both macroH2A1 splice variants appear to promote ALT as a result of ATRX loss, they do so via distinct molecular pathways, consistent with differential roles for these variants during other cellular processes, including DSB repair and cell growth 38 .
Finally, it is worth noting that macroH2A1.2 is not only enriched at ALT telomeres but also at telomeres of ATRX-expressing, ALT-negative tumor cell lines, albeit at lower levels (Fig. 1a ). MacroH2A1.2 function at telomeres is, thus, unlikely to be restricted to ALT cells. Indeed, experimental deletion of macroH2A1.2 causes aberrant, telomeric DNA damage in ALT-negative cells (Fig. 4a ). This genome-protective function of macroH2A1.2 may explain how restoration of ATRX, which prevents telomeric macroH2A1.2 loss on RS in ALT-positive cells, counteracts the accumulation of the DSB repair effector MRE11 at ALT telomeres 6 . Together, our findings indicate that macroH2A1.2 may be targeted to modulate DNA damage formation and genome instability, particularly in ATRX-deficient ALT tumors, which are often characterized by a poor clinical prognosis.
Online content
Any methods, additional references, Nature Research reporting summaries, source data, statements of data availability and associated accession codes are available at https://doi.org/10.1038/ s41594-019-0192-3.
